BG108113A - N-заместени неарилови хетероциклени nmda/nr2b антагонисти - Google Patents
N-заместени неарилови хетероциклени nmda/nr2b антагонисти Download PDFInfo
- Publication number
- BG108113A BG108113A BG108113A BG10811303A BG108113A BG 108113 A BG108113 A BG 108113A BG 108113 A BG108113 A BG 108113A BG 10811303 A BG10811303 A BG 10811303A BG 108113 A BG108113 A BG 108113A
- Authority
- BG
- Bulgaria
- Prior art keywords
- alkyl
- chloro
- fluoro
- compound
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27110001P | 2001-02-23 | 2001-02-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
BG108113A true BG108113A (bg) | 2005-04-30 |
Family
ID=23034191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG108113A BG108113A (bg) | 2001-02-23 | 2003-08-19 | N-заместени неарилови хетероциклени nmda/nr2b антагонисти |
Country Status (33)
Country | Link |
---|---|
US (2) | US7217716B2 (de) |
EP (1) | EP1379520B2 (de) |
JP (1) | JP4179879B2 (de) |
KR (1) | KR100849839B1 (de) |
CN (1) | CN100567293C (de) |
AT (1) | ATE324371T1 (de) |
AU (1) | AU2002252053B2 (de) |
BG (1) | BG108113A (de) |
BR (1) | BR0207526A (de) |
CA (1) | CA2438895A1 (de) |
CZ (1) | CZ20032258A3 (de) |
DE (1) | DE60210944T3 (de) |
DK (1) | DK1379520T3 (de) |
EA (1) | EA005974B1 (de) |
EC (1) | ECSP034744A (de) |
EE (1) | EE200300403A (de) |
ES (1) | ES2261658T3 (de) |
GE (1) | GEP20063741B (de) |
HR (1) | HRP20030669A2 (de) |
HU (1) | HUP0303258A3 (de) |
IL (2) | IL157254A0 (de) |
IS (1) | IS6902A (de) |
MX (1) | MXPA03007621A (de) |
NO (1) | NO20033732L (de) |
NZ (1) | NZ527365A (de) |
PL (1) | PL364625A1 (de) |
PT (1) | PT1379520E (de) |
SI (1) | SI1379520T1 (de) |
SK (1) | SK10542003A3 (de) |
UA (1) | UA75392C2 (de) |
WO (1) | WO2002068409A1 (de) |
YU (1) | YU64303A (de) |
ZA (1) | ZA200306159B (de) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1399160A4 (de) * | 2001-06-12 | 2004-08-25 | Merck & Co Inc | Nr2b-rezeptor-antagonisten zur behandlung oder prävention von migräne |
WO2003048140A1 (fr) * | 2001-12-03 | 2003-06-12 | Japan Tobacco Inc. | Compose azole et utilisation medicinale de celui-ci |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
CN1642422A (zh) * | 2002-03-15 | 2005-07-20 | 西巴特殊化学品控股有限公司 | 4-氨基嘧啶及其在表面抗菌处理中的应用 |
US6924285B2 (en) | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
US7517875B2 (en) | 2002-04-16 | 2009-04-14 | Teijin Limited | Piperidine derivatives having CCR3 antagonism |
WO2003091245A1 (fr) | 2002-04-25 | 2003-11-06 | Teijin Limited | Derives de piperidine 4,4 disubstitues a antagonisme pour ccr3 |
JP2004315511A (ja) * | 2003-03-31 | 2004-11-11 | Taisho Pharmaceut Co Ltd | Mch受容体アンタゴニスト |
US7592360B2 (en) | 2003-06-04 | 2009-09-22 | Merck & Co., Inc. | 3-fluoro-piperidines as NMDA/NR2B antagonists |
EP1648882B1 (de) * | 2003-06-04 | 2008-08-06 | Merck & Co., Inc. | 3-fluoro-piperidine als nmda/nr2b antagonisten |
PL1656372T3 (pl) | 2003-07-30 | 2013-08-30 | Rigel Pharmaceuticals Inc | Związki 2,4-pirymidynodiaminy do stosowania w leczeniu lub zapobieganiu chorobom autoimmunologicznym |
CN1914182B (zh) | 2004-02-03 | 2011-09-07 | 阿斯利康(瑞典)有限公司 | 喹唑啉衍生物 |
JP2008509139A (ja) * | 2004-08-03 | 2008-03-27 | メルク エンド カムパニー インコーポレーテッド | 1,3−二置換ヘテロアリールnmda/nr2b拮抗薬 |
JP2008512417A (ja) * | 2004-09-10 | 2008-04-24 | ユセベ ファルマ ソシエテ アノニム | シグマ受容体リガンド |
US7776869B2 (en) | 2004-10-18 | 2010-08-17 | Amgen Inc. | Heteroaryl-substituted alkyne compounds and method of use |
AU2006264649A1 (en) | 2005-06-30 | 2007-01-11 | Prosidion Limited | GPCR agonists |
JO2769B1 (en) | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor |
CN101346368A (zh) * | 2005-12-21 | 2009-01-14 | 詹森药业有限公司 | 作为α2C-肾上腺素受体拮抗剂的取代的吡嗪酮衍生物 |
WO2007099828A1 (ja) * | 2006-02-23 | 2007-09-07 | Shionogi & Co., Ltd. | 環式基で置換された含窒素複素環誘導体 |
EP2007373A4 (de) * | 2006-03-29 | 2012-12-19 | Foldrx Pharmaceuticals Inc | Hemmung der alpha-synuclein-toxizität |
EP1921070A1 (de) | 2006-11-10 | 2008-05-14 | Boehringer Ingelheim Pharma GmbH & Co. KG | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung |
CN101547917A (zh) * | 2006-12-08 | 2009-09-30 | 霍夫曼-拉罗奇有限公司 | 用作jnk调节剂的取代的嘧啶类化合物及它们的应用 |
JO2642B1 (en) | 2006-12-08 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
JP5377332B2 (ja) | 2007-02-06 | 2013-12-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 二環式へテロ環、それらの化合物を含む薬剤、その使用及びその製法 |
JO2849B1 (en) | 2007-02-13 | 2015-03-15 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
RS52518B (en) * | 2007-04-23 | 2013-04-30 | Janssen Pharmaceutica N.V. | 4-ALCOXYPYRIDASINE DERIVATIVES AS A FAST DISSOCATING DOPAMINE 2 RECEPTOR ANTAGONISTS |
CN101663299A (zh) | 2007-04-23 | 2010-03-03 | 詹森药业有限公司 | 作为快速解离性多巴胺2受体拮抗剂的噻(二)唑类化合物 |
KR20150076264A (ko) * | 2007-08-22 | 2015-07-06 | 아스트라제네카 아베 | 시클로프로필 아미드 유도체 |
US20100249164A1 (en) * | 2007-10-31 | 2010-09-30 | Renger John J | Modulation of sleep with nr2b receptor antagonists |
CA2711582A1 (en) | 2008-02-07 | 2009-08-13 | Boehringer Ingelheim International Gmbh | Spirocyclic heterocycles, formulations containing said compounds, use thereof and processes for the preparation thereof |
WO2009138781A1 (en) | 2008-05-13 | 2009-11-19 | Astrazeneca Ab | Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy}quinazoline |
WO2010000456A1 (en) | 2008-07-03 | 2010-01-07 | Janssen Pharmaceutica Nv | Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists |
HUE033768T2 (en) | 2008-07-31 | 2017-12-28 | Janssen Pharmaceutica Nv | Piperazin-1-yl-trifluoromethyl-substituted pyridines as rapidly dissociating dopamine-2 receptor antagonists |
JP5539351B2 (ja) | 2008-08-08 | 2014-07-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | シクロヘキシルオキシ置換ヘテロ環、これらの化合物を含有する医薬、およびそれらを生成するための方法 |
TW201039825A (en) * | 2009-02-20 | 2010-11-16 | Astrazeneca Ab | Cyclopropyl amide derivatives 983 |
US8389536B2 (en) | 2009-10-27 | 2013-03-05 | Hoffmann-La Roche Inc. | Positive allosteric modulators (PAM) |
RU2012136921A (ru) * | 2010-02-18 | 2014-03-27 | Астразенека Аб | Твердые формы, содержащие производные циклопропиламида |
TWI520945B (zh) | 2010-02-18 | 2016-02-11 | 阿斯特捷利康公司 | 環丙基苯甲醯胺衍生物之新穎結晶形式 |
AU2010363329A1 (en) | 2010-11-07 | 2013-05-09 | Targegen, Inc. | Compositions and methods for treating myelofibrosis |
WO2012130905A1 (en) * | 2011-03-31 | 2012-10-04 | Bayer Pharma Aktiengesellschaft | Substituted benzimidazoles |
US8722670B2 (en) * | 2011-09-30 | 2014-05-13 | Bristol-Myers Squibb Company | Selective NR2B antagonists |
WO2013156614A1 (en) | 2012-04-20 | 2013-10-24 | Ucb Pharma S.A. | Methods for treating parkinson's disease |
JP2016028017A (ja) * | 2012-12-13 | 2016-02-25 | 大正製薬株式会社 | フッ素置換ピペリジン化合物 |
JP2017001954A (ja) * | 2013-11-08 | 2017-01-05 | 石原産業株式会社 | 含窒素飽和複素環化合物 |
EP3150598B1 (de) * | 2014-05-28 | 2019-02-13 | TOA Eiyo Ltd. | Substituierte tropanderivate |
CN106795163B (zh) * | 2014-06-04 | 2019-07-30 | 卢郡控股(开曼)有限公司 | 作为nr2b nmda受体拮抗剂的二氟乙基吡啶衍生物 |
CA2957898C (en) * | 2014-09-15 | 2023-02-21 | Rugen Holdings (Cayman) Limited | Pyrrolopyrimidine derivatives as nr2b nmda receptor antagonists |
WO2016100349A2 (en) * | 2014-12-16 | 2016-06-23 | Rugen Holdings (Cayman) Limited | Bicyclic azaheterocyclic compounds as nr2b nmda receptor antagonists |
WO2016126869A1 (en) | 2015-02-04 | 2016-08-11 | Rugen Holdings (Cayman) Limited | 3,3-difluoro-piperidine derivatives as nr2b nmda receptor antagonists |
EP3872073A1 (de) | 2015-05-11 | 2021-09-01 | Basf Se | Verfahren zur herstellung von 4-amino-pyridazinen |
CN107849010B (zh) | 2015-06-01 | 2021-11-09 | 卢郡控股(开曼)有限公司 | 作为nr2b nmda受体拮抗剂的3,3‐二氟哌啶氨基甲酸酯杂环化合物 |
WO2018098128A1 (en) | 2016-11-22 | 2018-05-31 | Rugen Holdings (Cayman) Limited | Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders |
BR112020017159A2 (pt) * | 2018-02-23 | 2020-12-22 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Inibidores de glutaminil ciclases bacterianas para uso no tratamento de doenças periodontais e relacionadas |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL265777A (de) | 1960-06-09 | |||
DE2341965C3 (de) | 1973-08-20 | 1979-01-25 | C.H. Boehringer Sohn, 6507 Ingelheim | 4- [N- (o-PyridyD- N-acyl] -aminolphenäthylpiperidine, Verfahren zu deren Herstellung sowie deren Verwendung bei der Bekämpfung von Schmerzzuständen |
US4197304A (en) | 1975-09-23 | 1980-04-08 | Janssen Pharmaceutica N.V. | N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides |
EP0126087A1 (de) * | 1982-09-24 | 1984-11-28 | Beecham Group Plc | Amino-azabicycloalkyl-derivate als dopamin-antagonisten |
RU2099339C1 (ru) | 1990-02-06 | 1997-12-20 | Пфайзер Инк. | Производные пиперидина |
PL169267B1 (pl) | 1990-05-10 | 1996-06-28 | Pfizer | Sposób wytwarzania nowej racemicznej lub optycznie czynnej pochodnej indolu PL PL PL PL PL PL |
US5189036A (en) | 1990-06-20 | 1993-02-23 | Schering Ag | Imidazolylbenzoyl substituted heterocycles |
EP0584192A1 (de) | 1991-04-18 | 1994-03-02 | Pfizer Inc. | Prodrug-ester von phenolischen 2-piperidino-1-alkanolen |
WO1993002052A1 (en) | 1991-07-17 | 1993-02-04 | Pfizer Inc. | 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents |
MY110227A (en) | 1991-08-12 | 1998-03-31 | Ciba Geigy Ag | 1-acylpiperindine compounds. |
SI9300097B (en) * | 1992-02-27 | 2001-12-31 | Janssen Pharmaceutica Nv | (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines |
DK55192D0 (da) * | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
US5436255A (en) | 1992-07-23 | 1995-07-25 | Pfizer Inc. | Method of treating diseases susceptable to treatment by blocking NMDA-receptors |
DE4241632A1 (de) | 1992-12-10 | 1994-06-16 | Thomae Gmbh Dr K | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
SG90035A1 (en) | 1992-12-21 | 2002-07-23 | Smithkline Beecham Corp | Bicyclic fibrinogen antagonists |
DE4304650A1 (de) | 1993-02-16 | 1994-08-18 | Thomae Gmbh Dr K | Kondensierte 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
JPH09503994A (ja) | 1993-03-03 | 1997-04-22 | イーライ・リリー・アンド・カンパニー | バラノイド |
AU679045B2 (en) | 1993-03-18 | 1997-06-19 | Merck Sharp & Dohme Limited | Benzimidazole derivatives |
WO1996002250A1 (en) | 1994-07-20 | 1996-02-01 | Acea Pharmaceuticals Inc. | Haloperidol analogs and the use thereof |
US5661161A (en) | 1994-09-29 | 1997-08-26 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
EP0742208A1 (de) | 1995-05-05 | 1996-11-13 | Grelan Pharmaceutical Co., Ltd. | 2-Ureido-benzamid-Derivate |
CA2219911C (en) | 1995-05-26 | 2004-07-27 | Pfizer Inc. | Combinations for the treatment of parkinsonism containing selective nmda antagonists |
DE19541264A1 (de) | 1995-11-06 | 1997-05-07 | Bayer Ag | Purin-6-on-derivate |
EP0771779B1 (de) | 1995-11-06 | 2002-05-02 | Kuraray Co., Ltd. | Verfahren zur Herstellung von Acetalen |
GB9523675D0 (en) * | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
ZA9610745B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
FR2744449B1 (fr) | 1996-02-02 | 1998-04-24 | Pf Medicament | Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments |
EP0787493A1 (de) | 1996-02-03 | 1997-08-06 | F. Hoffmann-La Roche Ag | Tetrahydroisochinolin-Derivate |
TW504510B (en) * | 1996-05-10 | 2002-10-01 | Janssen Pharmaceutica Nv | 2,4-diaminopyrimidine derivatives |
AU2898297A (en) | 1996-05-24 | 1998-01-05 | Novartis Ag | Use of substance p antagonists for treating social phobia |
BR9710570A (pt) | 1996-07-25 | 2005-06-28 | Biogen Inc | Inibidor de adesão de células |
DZ2285A1 (fr) | 1996-08-08 | 2002-12-25 | Smithkline Beecham Corp | Inhibiteurs de protéase de la cystéine. |
EP0846683B1 (de) | 1996-12-03 | 2001-09-19 | F. Hoffmann-La Roche Ag | 4-Hydroxypiperidinderivate |
FR2758328B1 (fr) | 1997-01-15 | 1999-04-02 | Pf Medicament | Nouvelles amines aromatiques derivees d'amines cycliques utiles comme medicaments |
FR2758327B1 (fr) | 1997-01-15 | 1999-04-02 | Pf Medicament | Nouvelles arylpiperazines derivees de piperidine |
IT1291569B1 (it) | 1997-04-15 | 1999-01-11 | Angelini Ricerche Spa | Indazolammidi come agenti serotoninergici |
WO1999025685A1 (en) | 1997-11-18 | 1999-05-27 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
US6020347A (en) | 1997-11-18 | 2000-02-01 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
DE19815026A1 (de) * | 1998-04-03 | 1999-10-07 | Hoechst Schering Agrevo Gmbh | Substituierte Piperidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide |
PE20000728A1 (es) | 1998-06-26 | 2000-08-21 | Cocensys Inc | Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda |
ES2261844T3 (es) | 1998-08-07 | 2006-11-16 | Applied Research Systems Ars Holding N.V. | Mimeticos de la fsh para el tratamiento de la infertilidad. |
DE19838300A1 (de) | 1998-08-24 | 2000-03-02 | Bayer Ag | 9-Dialkylaminopurinon-derivate |
US6303637B1 (en) | 1998-10-30 | 2001-10-16 | Merck & Co., Inc. | Heterocyclic potassium channel inhibitors |
WO2000061551A2 (de) | 1999-04-13 | 2000-10-19 | Basf Aktiengesellschaft | Pyrimidin-2-on derivate als integrinrezeptorliganden |
AU6605200A (en) | 1999-06-30 | 2001-01-31 | Merck & Co., Inc. | Src kinase inhibitor compounds |
-
2002
- 2002-02-20 EE EEP200300403A patent/EE200300403A/xx unknown
- 2002-02-20 AT AT02721105T patent/ATE324371T1/de not_active IP Right Cessation
- 2002-02-20 SK SK1054-2003A patent/SK10542003A3/sk not_active Application Discontinuation
- 2002-02-20 MX MXPA03007621A patent/MXPA03007621A/es active IP Right Grant
- 2002-02-20 CA CA002438895A patent/CA2438895A1/en not_active Abandoned
- 2002-02-20 IL IL15725402A patent/IL157254A0/xx active IP Right Grant
- 2002-02-20 US US10/470,561 patent/US7217716B2/en not_active Expired - Fee Related
- 2002-02-20 JP JP2002567923A patent/JP4179879B2/ja not_active Expired - Fee Related
- 2002-02-20 DK DK02721105T patent/DK1379520T3/da active
- 2002-02-20 ES ES02721105T patent/ES2261658T3/es not_active Expired - Lifetime
- 2002-02-20 KR KR1020037011079A patent/KR100849839B1/ko not_active IP Right Cessation
- 2002-02-20 PL PL02364625A patent/PL364625A1/xx not_active Application Discontinuation
- 2002-02-20 BR BR0207526-1A patent/BR0207526A/pt not_active IP Right Cessation
- 2002-02-20 CZ CZ20032258A patent/CZ20032258A3/cs unknown
- 2002-02-20 PT PT02721105T patent/PT1379520E/pt unknown
- 2002-02-20 UA UA2003098659A patent/UA75392C2/uk unknown
- 2002-02-20 HU HU0303258A patent/HUP0303258A3/hu unknown
- 2002-02-20 AU AU2002252053A patent/AU2002252053B2/en not_active Ceased
- 2002-02-20 US US10/079,452 patent/US7053089B2/en not_active Expired - Lifetime
- 2002-02-20 EA EA200300919A patent/EA005974B1/ru not_active IP Right Cessation
- 2002-02-20 WO PCT/US2002/005226 patent/WO2002068409A1/en active IP Right Grant
- 2002-02-20 EP EP02721105.1A patent/EP1379520B2/de not_active Expired - Lifetime
- 2002-02-20 GE GE5284A patent/GEP20063741B/en unknown
- 2002-02-20 CN CNB028087135A patent/CN100567293C/zh not_active Expired - Fee Related
- 2002-02-20 SI SI200230322T patent/SI1379520T1/sl unknown
- 2002-02-20 NZ NZ527365A patent/NZ527365A/en unknown
- 2002-02-20 YU YU64303A patent/YU64303A/sh unknown
- 2002-02-20 DE DE60210944.2T patent/DE60210944T3/de not_active Expired - Lifetime
-
2003
- 2003-07-31 IS IS6902A patent/IS6902A/is unknown
- 2003-08-05 IL IL157254A patent/IL157254A/en not_active IP Right Cessation
- 2003-08-08 ZA ZA200306159A patent/ZA200306159B/en unknown
- 2003-08-19 BG BG108113A patent/BG108113A/bg unknown
- 2003-08-22 HR HR20030669A patent/HRP20030669A2/hr not_active Application Discontinuation
- 2003-08-22 NO NO20033732A patent/NO20033732L/no not_active Application Discontinuation
- 2003-08-22 EC EC2003004744A patent/ECSP034744A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG108113A (bg) | N-заместени неарилови хетероциклени nmda/nr2b антагонисти | |
AU2002252053A1 (en) | N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists | |
JP6570001B2 (ja) | Alkキナーゼ阻害剤 | |
AU2017258187B2 (en) | Isoquinolin-3-yl carboxamides and preparation and use thereof | |
RU2568434C2 (ru) | Пиримидиновые соединения для использования в качестве модуляторов дельта-опиоидных рецепторов | |
JP5166280B2 (ja) | ピリミジン誘導体 | |
AU2010313397B2 (en) | Phenoxy-substituted pyrimidines as opioid receptor modulators | |
JP2018035184A (ja) | Btk阻害剤としての4−イミダゾピリダジン−1−イル−ベンズアミドおよび4−イミダゾトリアジン−1−イル−ベンズアミド | |
CA2603876A1 (en) | N-alkyl-azacycloalkyl nmda/nr2b antagonists | |
JPWO2002040019A1 (ja) | ベンズイミダゾール誘導体 | |
KR101794321B1 (ko) | 바이사이클릭 그룹 치환된 피리미딘 화합물 | |
WO2020085234A1 (ja) | モルヒナン誘導体 | |
US20090124600A1 (en) | N-Alkyl-Azacycloalkyl NMDA/NR2B Antagonists | |
JP2002161095A (ja) | 1h−イミダゾピリジン誘導体 |